Clinical Trials Browser

Phase 1/2 × Chlorpromazine × Clear all

NCT05433402 2022-10-27

Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms